[A multicenter, randomized, parallel, controlled, prospective, open-label study of the efficiency and safety of bovhyaluronidase azoximer in combination therapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia].
Our results indicate greater efficiency and safety of combination therapy with Longidaza and tamsulosin in patients with LUTS due to BPH compared to monotherapy with tamsulosin.
Authors
- С. В. Шорманов
- Singer A (ORCID: https://orcid.org/0009-0002-4417-0100)
- Ide P
- Vij A
- K O
Institutions
- Kuban State Medical University (RU)
- Yaroslavl State Medical Academy (RU)
- First Pavlov State Medical University of St. Petersburg (RU)
- Russian New University (RU)
- Krasnodar Municipal Medical Institute of Higher Nursing Education (RU)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00